EIDD-1931

• Description:

  EIDD-1931 (Beta-d-N4-hydroxycytidine; NHC) is a novel nucleoside analog and behaves as a potent anti-virus agent. EIDD-1931 effectively inhibits the replication activity of venezuelan equine encephalitis virus (VEEV), Chikungunya virus (CHIKV) and hepatitis C virus (HCV) [1].

• Product Name Alternative:

  β-D-N4-hydroxycytidine; NHC

• UNSPSC:

  12352005

• Hazard Statement:

  H228, H315, H319

• Target:

  CHIKV; Enterovirus; HCV; SARS-CoV; Topoisomerase

• Type:

  Reference compound

• Related Pathways:

  Anti-infection; Cell Cycle/DNA Damage

• Applications:

  Neuroscience-Neuromodulation

• Field of Research:

  Infection

• Assay Protocol:

  https://www.medchemexpress.com/beta-d-n4-hydroxycytidine.html

• Purity:

  99.98

• Solubility:

  DMSO : 100 mg/mL (ultrasonic) |H2O : ≥ 25 mg/mL

• Smiles:

  O=C(N/1)N([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)C=CC1=N/O

• Molecular Formula:

  C9H13N3O6

• Molecular Weight:

  259.22

• Precautions:

  H228, H315, H319

• References & Citations:

  4

• Shipping Conditions:

  Room Temperature

• Storage Conditions:

  -20°C, 3 years; 4°C, 2 years (Powder)

• Scientific Category:

  Reference compound1

• Clinical Information:

  No Development Reported

• CAS Number:

  3258-02-4